Ky, Bonnie

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

Curigliano, G., Lenihan, D., Fradley, M., Ganatra, S., Barac, A., Blaes, A., Herrmann, J., Porter, C., Lyon, A. R., Lancellotti, P., et al. (2020) · Annals of Oncology

Chemotherapy-induced cardiotoxicity and mitigationCardiac tumors and thrombi

Cited by 1,031

Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis

Waxman, A. J., Clasen, S., Hwang, W.-T., Garfall, A., Vogl, D. T., Carver, J., O’Quinn, R., Cohen, A. D., Stadtmauer, E. A., Ky, B., et al. (2018) · JAMA Oncology

Chemotherapy-induced cardiotoxicity and mitigationMultiple Myeloma Research and Treatments

Cited by 286

Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma

Cornell, R. F., Ky, B., Weiss, B. M., Dahm, C. N., Gupta, D. K., Du, L., Carver, J. R., Cohen, A. D., Engelhardt, B. G., Garfall, A. L., et al. (2019) · Journal of Clinical Oncology

Chemotherapy-induced cardiotoxicity and mitigationMultiple Myeloma Research and Treatments

Cited by 198

Observational cohort study of the safety of digoxin use in women with heart failure

Flory, J. H., Ky, B., Haynes, K., M Brunelli, S., Munson, J., Rowan, C., Strom, B. L., & Hennessy, S. (2012) · BMJ Open

Heart Failure Treatment and ManagementPharmaceutical Practices and Patient Outcomes

Cited by 27